Pinoline may be used as a probe for CYP2D6 activity

Xi Ling Jiang, Hong Wu Shen, Aiming Yu

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Pinoline, 6-methoxy-1,2,3,4-tetrahydro-β-carboline, is a serotonin analog that selectively inhibits the activity of monoamine oxidase-A and shows antidepressant activity. Our previous study using a panel of recombinant cytochrome P450 (P450) enzymes suggests that pinoline O-demethylation may be selectively catalyzed by polymorphic CYP2D6. The current study, therefore, aimed to delineate the impact of CYP2D6 status on pinoline metabolism. Enzyme kinetic studies using recombinant CYP2D6 allelic isozymes revealed that CYP2D6.2 exhibited 5-fold lower enzyme efficiency (V max/K m) toward pinoline compared with CYP2D6.1, and CYP2D6.10 did not show any catalytic activity. Inhibition study showed that quinidine (1 μM) completely blocked pinoline O-demethylase activity in human liver microsomes, whereas other P450 isoform-selective inhibitors had no or minimal effects. Pinoline O-demethylase activities in 10 human liver microsomes showed significantly strong correlation with bufuralol 1′-hydroxylase activities (R 2 = 0.93; p < 0.0001) and CYP2D6 contents (R 2 = 0.82; p = 0.005), whereas no appreciable correlations with enzymatic activities of other P450 enzymes were found. Furthermore, we compared pinoline urinary metabolic ratio (pinoline/6-hydroxy-1,2,3,4-tetrahydro-β-carboline) between CVP2D6-humanized and wild-type control mice after intraperitoneal injection of pinoline (30 mg/kg). Results indicated that the two genotyped mice were clearly distinguished by pinoline metabolic ratio (mean ± S.D.), which was much higher in wild-type mice (0.29 ± 0.19, n = 4) than in CVP2D6-humanized transgenic mice (0.0070 ± 0.0048, n = 4). Our findings suggest that pinoline O-demethylation is governed by CYP2D6 status, and pinoline, at a proper concentration or dose, may be a good probe to evaluate CYP2D6 activity.

Original languageEnglish (US)
Pages (from-to)443-446
Number of pages4
JournalDrug Metabolism and Disposition
Volume37
Issue number3
DOIs
StatePublished - Mar 2009
Externally publishedYes

Fingerprint

Cytochrome P-450 CYP2D6
O Demethylating Oxidoreductases
Cytochrome P-450 Enzyme System
Carbolines
Liver Microsomes
6-methoxytryptoline
Quinidine
Monoamine Oxidase
Enzymes
Intraperitoneal Injections
Human Activities
Transgenic Mice
Antidepressive Agents
Isoenzymes
Serotonin
Protein Isoforms

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Pinoline may be used as a probe for CYP2D6 activity. / Jiang, Xi Ling; Shen, Hong Wu; Yu, Aiming.

In: Drug Metabolism and Disposition, Vol. 37, No. 3, 03.2009, p. 443-446.

Research output: Contribution to journalArticle

Jiang, Xi Ling ; Shen, Hong Wu ; Yu, Aiming. / Pinoline may be used as a probe for CYP2D6 activity. In: Drug Metabolism and Disposition. 2009 ; Vol. 37, No. 3. pp. 443-446.
@article{696bfea863e24d0c935ad59fd7aadb0d,
title = "Pinoline may be used as a probe for CYP2D6 activity",
abstract = "Pinoline, 6-methoxy-1,2,3,4-tetrahydro-β-carboline, is a serotonin analog that selectively inhibits the activity of monoamine oxidase-A and shows antidepressant activity. Our previous study using a panel of recombinant cytochrome P450 (P450) enzymes suggests that pinoline O-demethylation may be selectively catalyzed by polymorphic CYP2D6. The current study, therefore, aimed to delineate the impact of CYP2D6 status on pinoline metabolism. Enzyme kinetic studies using recombinant CYP2D6 allelic isozymes revealed that CYP2D6.2 exhibited 5-fold lower enzyme efficiency (V max/K m) toward pinoline compared with CYP2D6.1, and CYP2D6.10 did not show any catalytic activity. Inhibition study showed that quinidine (1 μM) completely blocked pinoline O-demethylase activity in human liver microsomes, whereas other P450 isoform-selective inhibitors had no or minimal effects. Pinoline O-demethylase activities in 10 human liver microsomes showed significantly strong correlation with bufuralol 1′-hydroxylase activities (R 2 = 0.93; p < 0.0001) and CYP2D6 contents (R 2 = 0.82; p = 0.005), whereas no appreciable correlations with enzymatic activities of other P450 enzymes were found. Furthermore, we compared pinoline urinary metabolic ratio (pinoline/6-hydroxy-1,2,3,4-tetrahydro-β-carboline) between CVP2D6-humanized and wild-type control mice after intraperitoneal injection of pinoline (30 mg/kg). Results indicated that the two genotyped mice were clearly distinguished by pinoline metabolic ratio (mean ± S.D.), which was much higher in wild-type mice (0.29 ± 0.19, n = 4) than in CVP2D6-humanized transgenic mice (0.0070 ± 0.0048, n = 4). Our findings suggest that pinoline O-demethylation is governed by CYP2D6 status, and pinoline, at a proper concentration or dose, may be a good probe to evaluate CYP2D6 activity.",
author = "Jiang, {Xi Ling} and Shen, {Hong Wu} and Aiming Yu",
year = "2009",
month = "3",
doi = "10.1124/dmd.108.025056",
language = "English (US)",
volume = "37",
pages = "443--446",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Pinoline may be used as a probe for CYP2D6 activity

AU - Jiang, Xi Ling

AU - Shen, Hong Wu

AU - Yu, Aiming

PY - 2009/3

Y1 - 2009/3

N2 - Pinoline, 6-methoxy-1,2,3,4-tetrahydro-β-carboline, is a serotonin analog that selectively inhibits the activity of monoamine oxidase-A and shows antidepressant activity. Our previous study using a panel of recombinant cytochrome P450 (P450) enzymes suggests that pinoline O-demethylation may be selectively catalyzed by polymorphic CYP2D6. The current study, therefore, aimed to delineate the impact of CYP2D6 status on pinoline metabolism. Enzyme kinetic studies using recombinant CYP2D6 allelic isozymes revealed that CYP2D6.2 exhibited 5-fold lower enzyme efficiency (V max/K m) toward pinoline compared with CYP2D6.1, and CYP2D6.10 did not show any catalytic activity. Inhibition study showed that quinidine (1 μM) completely blocked pinoline O-demethylase activity in human liver microsomes, whereas other P450 isoform-selective inhibitors had no or minimal effects. Pinoline O-demethylase activities in 10 human liver microsomes showed significantly strong correlation with bufuralol 1′-hydroxylase activities (R 2 = 0.93; p < 0.0001) and CYP2D6 contents (R 2 = 0.82; p = 0.005), whereas no appreciable correlations with enzymatic activities of other P450 enzymes were found. Furthermore, we compared pinoline urinary metabolic ratio (pinoline/6-hydroxy-1,2,3,4-tetrahydro-β-carboline) between CVP2D6-humanized and wild-type control mice after intraperitoneal injection of pinoline (30 mg/kg). Results indicated that the two genotyped mice were clearly distinguished by pinoline metabolic ratio (mean ± S.D.), which was much higher in wild-type mice (0.29 ± 0.19, n = 4) than in CVP2D6-humanized transgenic mice (0.0070 ± 0.0048, n = 4). Our findings suggest that pinoline O-demethylation is governed by CYP2D6 status, and pinoline, at a proper concentration or dose, may be a good probe to evaluate CYP2D6 activity.

AB - Pinoline, 6-methoxy-1,2,3,4-tetrahydro-β-carboline, is a serotonin analog that selectively inhibits the activity of monoamine oxidase-A and shows antidepressant activity. Our previous study using a panel of recombinant cytochrome P450 (P450) enzymes suggests that pinoline O-demethylation may be selectively catalyzed by polymorphic CYP2D6. The current study, therefore, aimed to delineate the impact of CYP2D6 status on pinoline metabolism. Enzyme kinetic studies using recombinant CYP2D6 allelic isozymes revealed that CYP2D6.2 exhibited 5-fold lower enzyme efficiency (V max/K m) toward pinoline compared with CYP2D6.1, and CYP2D6.10 did not show any catalytic activity. Inhibition study showed that quinidine (1 μM) completely blocked pinoline O-demethylase activity in human liver microsomes, whereas other P450 isoform-selective inhibitors had no or minimal effects. Pinoline O-demethylase activities in 10 human liver microsomes showed significantly strong correlation with bufuralol 1′-hydroxylase activities (R 2 = 0.93; p < 0.0001) and CYP2D6 contents (R 2 = 0.82; p = 0.005), whereas no appreciable correlations with enzymatic activities of other P450 enzymes were found. Furthermore, we compared pinoline urinary metabolic ratio (pinoline/6-hydroxy-1,2,3,4-tetrahydro-β-carboline) between CVP2D6-humanized and wild-type control mice after intraperitoneal injection of pinoline (30 mg/kg). Results indicated that the two genotyped mice were clearly distinguished by pinoline metabolic ratio (mean ± S.D.), which was much higher in wild-type mice (0.29 ± 0.19, n = 4) than in CVP2D6-humanized transgenic mice (0.0070 ± 0.0048, n = 4). Our findings suggest that pinoline O-demethylation is governed by CYP2D6 status, and pinoline, at a proper concentration or dose, may be a good probe to evaluate CYP2D6 activity.

UR - http://www.scopus.com/inward/record.url?scp=61449111025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61449111025&partnerID=8YFLogxK

U2 - 10.1124/dmd.108.025056

DO - 10.1124/dmd.108.025056

M3 - Article

C2 - 19095720

AN - SCOPUS:61449111025

VL - 37

SP - 443

EP - 446

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 3

ER -